Corbion N.V. (AMS:CRBN)
Netherlands · Delayed Price · Currency is EUR 19.82
-0.03 (-0.15%)
Aug 27, 2026, 5:35 PM CET
Corbion Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,253 | 1,267 | 1,288 | 1,264 | 1,458 | 1,071 | |
Revenue Growth | -3.37% | -1.61% | 1.90% | -13.29% | 36.15% | 8.54% |
Cost of Revenue | 939 | 932.7 | 968.5 | 979.9 | 1,132 | 801.8 |
Gross Profit | 313.9 | 334.7 | 319.6 | 284.2 | 326.4 | 269 |
Selling, General & Admin | 170.1 | 173.8 | 182.7 | 176 | 171.2 | 154.6 |
Research & Development | 43.6 | 42.5 | 46.3 | 45.6 | 47.2 | 42.6 |
Operating Expenses | 213.7 | 216.3 | 229 | 221.6 | 218.4 | 197.2 |
Operating Income | 100.2 | 118.4 | 90.6 | 62.6 | 108 | 71.8 |
Interest Expense | -11.7 | -15.2 | -20 | -27 | -15.8 | -11.5 |
Interest & Investment Income | 6.8 | 4.6 | 5.8 | 6.4 | 3.4 | 1.9 |
Earnings From Equity Investments | -3 | -4.1 | -3.6 | -3.5 | 10.9 | 18.7 |
Currency Exchange Gain (Loss) | - | - | 5.7 | -4 | 9.1 | -2.9 |
Other Non Operating Income (Expenses) | -6.8 | -6.8 | -2.6 | -3.7 | -2 | -1.8 |
EBT Excluding Unusual Items | 85.5 | 96.9 | 75.9 | 30.8 | 113.6 | 76.2 |
Gain (Loss) on Sale of Assets | - | - | - | - | 9.5 | 30.2 |
Asset Writedown | - | - | - | - | - | -20.4 |
Other Unusual Items | -5.2 | -2 | -13.4 | 14.6 | -6.7 | 0.5 |
Pretax Income | 80.3 | 94.9 | 62.5 | 45.4 | 116.4 | 86.5 |
Income Tax Expense | 18.1 | 20.1 | 16.6 | 2.3 | 26.4 | 8.2 |
Earnings From Continuing Operations | 62.2 | 74.8 | 45.9 | 43.1 | 90 | 78.3 |
Earnings From Discontinued Operations | - | - | 146.3 | 29.8 | - | - |
Net Income | 62.2 | 74.8 | 192.2 | 72.9 | 90 | 78.3 |
Net Income to Common | 62.2 | 74.8 | 192.2 | 72.9 | 90 | 78.3 |
Net Income Growth | -6.04% | -61.08% | 163.65% | -19.00% | 14.94% | 7.11% |
Shares Outstanding (Basic) | 58 | 58 | 58 | 59 | 59 | 59 |
Shares Outstanding (Diluted) | 59 | 59 | 59 | 60 | 60 | 59 |
Shares Change | -0.36% | -0.68% | -0.67% | 0.34% | 0.17% | -0.17% |
EPS (Basic) | 1.08 | 1.29 | 3.29 | 1.23 | 1.53 | 1.33 |
EPS (Diluted) | 1.06 | 1.27 | 3.24 | 1.22 | 1.51 | 1.32 |
EPS Growth | -5.35% | -60.77% | 165.52% | -19.26% | 14.39% | 7.32% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 75.6 | 92.7 | 99.9 | 16.1 | -196.8 | -126.3 |
Free Cash Flow Per Share | 1.29 | 1.57 | 1.69 | 0.27 | -3.31 | -2.13 |
Dividend Per Share | 0.640 | 0.640 | 0.640 | 0.610 | 0.560 | 0.560 |
Dividend Growth | 0% | 0% | 4.92% | 8.93% | 0% | 0% |
Gross Margin | 25.05% | 26.41% | 24.81% | 22.48% | 22.39% | 25.12% |
Operating Margin | 8.00% | 9.34% | 7.03% | 4.95% | 7.41% | 6.71% |
Profit Margin | 4.96% | 5.90% | 14.92% | 5.77% | 6.17% | 7.31% |
Free Cash Flow Margin | 6.03% | 7.31% | 7.76% | 1.27% | -13.50% | -11.79% |
EBITDA | 169.7 | 187.5 | 160 | 130.2 | 166.7 | 132.6 |
EBITDA Margin | 13.54% | 14.79% | 12.42% | 10.30% | 11.43% | 12.38% |
D&A For EBITDA | 69.5 | 69.1 | 69.4 | 67.6 | 58.7 | 60.8 |
EBIT | 100.2 | 118.4 | 90.6 | 62.6 | 108 | 71.8 |
EBIT Margin | 8.00% | 9.34% | 7.03% | 4.95% | 7.41% | 6.71% |
Effective Tax Rate | 22.54% | 21.18% | 26.56% | 5.07% | 22.68% | 9.48% |